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Introduction
Opioid analgesics are potentially hazardous medications in young children. During the past
5 years, much attention has been drawn to the safety concerns of these medications.1–6
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Data evaluating pain control after injury among older children suggest that opioid drugs are
not more effective than nonopioids in treating pain secondary to acute traumatic injury.7,8
Postsurgical data evaluating children who underwent palatoplasty demonstrated that children
treated with nonopioid pain regimens did as well as subjects treated with morphine.9 More
concerning, opioid analgesics have been consistently demonstrated to be among the most
common drugs involved in accidental ingestions prompting emergency department visits and
rank consistently high as contributors to medication-related death in children.1 Data from
nonopioid medication studies have demonstrated that young children, particularly infants,
are at higher risk for experiencing drug errors and experiencing adverse outcomes should
they experience a dosing error.10 In previous studies, we demonstrated that children 0 to 36
months old who received opioid drugs received a potential overdose approximately 1.6% to
2.7% of the time, and the frequency of potential opioid overdose may be as high as 11.8%
among children 0 to 2 months old.11,12 In this brief report, we examined South Carolina
Medicaid data to determine the indications for receipt of opioid analgesics among subjects 0
to <6 months old.
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Method
The study retrospectively evaluated pharmacy claims from South Carolina Medicaid
prescriptions from January 1, 2011, through August 30, 2012, dispensed to subjects 0 to <6
months old. The unit of analysis for this study was the dispensed prescription. We studied 2
preparations—acetaminophen/codeine and acetaminophen/hydrocodone—the most common
opioid preparations prescribed to children aged 0 to 36 months.11 The data were provided to
the investigators in de-identified format, consisting of 3 Medicaid files: a pharmacy file
(dispensed prescriptions), enrollee file (with limited demographic data), and an outpatient
visit file that includes ambulatory surgeries (with visit diagnoses), all matched one to
another utilizing a unique identifier provided by the South Carolina Revenue and Fiscal
Affairs Office.
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Demographic data included race/ethnicity (ethnicity is not entered as a separate category but
is entered as a “racial” category, so Hispanic ethnicity was utilized as a “racial” category),
gender, and age in months. Enrollee demographic data were linked to each prescription. In
order to assess indications, we then linked prescriptions to corresponding diagnoses from the
visit data. We began with the date of the dispensed medication in the prescription file, and
then matched each prescription to the closest visit date in the outpatient visit data file. We
first began by searching for any outpatient visit in the 30 days prior to the prescription
dispensing date, then for 30 days after the prescription date, as described previously.13 Any
prescription for which we could not identify a corresponding outpatient visit was dropped
from analyses.
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Two investigators (WTB and JRR) viewed all of the diagnoses in the administrative record
that corresponded to the visit date. The authors classified each diagnosis based on a
grouping that included surgical diagnoses (eg, “talipes equinovarus,” “unilateral cleft lip”),
trauma/ trauma-related pain diagnoses (eg, “fracture”), respiratory diagnoses (eg,
“bronchiolitis,” “URI”), and “other” diagnoses (eg, well child check, any missing diagnosis).
Any visit that lacked a diagnosis was assigned as “other” diagnosis. The authors classified
each opioid prescription as “appropriate” (surgical and trauma/pain diagnoses) and
“inappropriate” (respiratory or “other” diagnoses). We calculated raw agreement between
the 2 reviewers on the question of whether the indication was appropriate or not, and we also
calculated the kappa statistic for agreement. Differences between the 2 reviewers were
addressed by discussion between the 2 reviewers and consensus. The analyses included a
description of the prescriptions, the recipients, and the diagnoses along with the frequency of
appropriate and inappropriate indications. The Institutional Review Board of the Medical
University of South Carolina approved the study.
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Results
In the 17 months of data reviewed, there were 67 opioid prescriptions prescribed to children
0 to <6 months old. The large majority of these prescriptions were for acetaminophen/
codeine (97%), with 3% for acetaminophen/hydrocodone. The mean age of the subjects
dispensed one of these preparations was 4.0 months, and 80.6% of the prescriptions were to
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male subjects. The race ethnicity breakdown of the subjects receiving the prescriptions was
47.8% white, 28.4% black, 13.4% Hispanic, and 10.2% other.
The 2 reviewers’ raw agreement on the determination of whether a prescription was
appropriate or not was 91%, with a kappa of 0.75. This falls into the classification of
“substantial” agreement. Review of the data revealed that 20.9% of the indications were
inappropriate, consisting of 9% respiratory diagnoses and 11.9% “other” diagnoses.
However, 79.1% of the indications were considered to be appropriate, with 73.1% of the
total being for surgical diagnoses and 6% being due to trauma/pain diagnoses. See Table 1
for a further breakdown of the distribution of the diagnostic categories by age, gender, and
race/ethnicity.
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The sample size was too small to allow rigorous statistical comparisons, but review of Table
1 reveals that no child <1 month old received one of the combination opioid drugs. While
surgical and other diagnoses were relatively evenly spread among the age categories, 100%
of the patients who received opioid for trauma/ pain and 83.3% of those who received opioid
for a respiratory diagnosis were in the oldest age stratum. While males comprised 80.6% of
the total subjects, they were 93.9% of those who received opioid for a surgical diagnosis but
only 33.3% of those who received opioid for a respiratory diagnosis. Urological diagnoses
were common in the data, representing 42% of all diagnoses among subjects prescribed one
of the acetaminophen/opioid drugs in this data set (data not separately shown in Table 1).

Discussion
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In this brief report reviewing acetaminophen/opioid prescriptions dispensed to subjects <6
months old, 1-in-5 prescriptions was for an inappropriate indication, and almost 1-in-10
were for respiratory diagnoses. While opioid products are approved by the US Food and
Drug Administration for cough suppression, use of opioids in this context is strongly
discouraged by professional organizations such as the American Academy of Pediatrics
owing to concerns about the safety of the drug class.14 In addition to safety concerns,
opioids have limited effectiveness controlling cough and other respiratory symptoms, yet
respiratory indications comprised 9% of the indications for opioid prescription in this
sample of infants <6 months old.15 Finally, the fact that combination opioids with
acetaminophen were prescribed for respiratory indications is particularly troubling given the
potential toxicities and risk of overdosing depending on which drug component and
respective range is used for dose calculations.12
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The large majority (79.1%) of the prescriptions to the subjects in this study were for
appropriate indications, either related to surgical indications (presumably to treat pain after a
surgical procedure for the surgical diagnosis) or posttraumatic pain. While opioids have US
Food and Drug Administration indications for treatment of pain in this population, there is a
concerning lack of research on their effectiveness compared to other analgesics in infants.
Randomized trials suggest that nonsteroidal anti-inflammatory medications may be equally
effective or even superior to opioids for pain control for fractures, but these studies evaluated
older patients (4–18 years) after emergency department evaluation for injury, whereas most
of the subjects in this study received opioids after surgery.7,8 We believe there is a striking
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need for similar research in infants after injury or planned surgery, especially given the
mounting concerns about the safety of opioids in this age group.
One potential area of focus going forward may be urological surgeries. We were surprised to
find that 42% of all indications were for urological diagnoses. Given the limited amount of
diagnostic data available in the administrative data sets, it is impossible to determine
whether any individual prescription might have been for a procedure to correct a major
urologic malformation or for something less complicated, such as circumcision. Many of the
diagnoses in the data set included “phimosis” or “redundant foreskin,” which may indicate a
simple circumcision, but the limited diagnostic information in these data limit detailed
conclusions. Regardless of the indication, the overrepresentation of urological procedures in
these infants who received opioids suggests a population of high priority for comparative
effectiveness research of opioid vs other pain control postprocedure.
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This study has notable limitations, including the fact that we only evaluated diagnoses
among 67 subjects. Nevertheless, these data are hypothesis-generating and suggest avenues
of future investigation. These data are from only one state, and adult data suggest wide
variation in opioid prescribing from state to state.16 For that reason, it is unclear how
generalizable these data are to other states. Not all diagnoses for a given visit may be present
in the administrative data. For example, several of the “other” category diagnoses included
“well child visit,” suggesting that a diagnosis that prompted the prescription of the opioid
may have been dealt with at the visit, but the diagnoses were not included because the visit
was billed as a health maintenance exam. While many of the visits had surgical diagnoses,
we were unable to tell if the patient actually had a procedure on that date. However,
prescription of an opioid linked to a visit with “inguinal hernia,” for example, suggests that
the opioid was prescribed after a procedure to correct the hernia.

Conclusions
Among subjects <6 months old who received a combination acetaminophen/opioid drug,
79.1% were for appropriate indications, primarily surgical diagnoses. The percentage of
prescriptions given for respiratory conditions is concerning. Given the safety concerns of
administering opioid drugs in infants, there appears to be an opportunity to conduct
comparative effectiveness studies that would evaluate the relative pain control and safety of
opioid versus nonopioid pain medications among infants.
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14 (28.6%)
16 (32.7%)

17 (25.4%)
26 (38.8%)

3 to <4

4 to <5

5 to <6

6 (12.2%)
6 (12.2%)
24 (49.0%)

9 (13.4%)
7 (10.5%)
32 (47.8%)

Hispanic

Other

White

3 (6.1%)
49 (73.1%)

13 (19.4%)
67 (100%)

Female

Total

46 (93.9%)

54 (80.6%)

Male

Gender

13 (26.5%)

19 (28.4%)

Black

4 (6.0%)

2 (50.0%)

2 (50.0%)

2 (50.0%)

0 (0.0%)

0 (0.0%)

2 (50.0%)

4 (100.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

6 (9.0%)

4 (66.7%)

2 (33.3%)

3 (50.0%)

0 (0.0%)

1 (16.7%)

2 (33.3%)

5 (83.3%)

0 (0.0%)

0 (0.0%)

1 (16.7%)

0 (0.0%)

0 (0.0%)

Respiratory Indicationc, n (%)

In South Carolina Medicaid data, Hispanic ethnicity is treated as a separate category, equal to race, rather than an ethnicity descriptor of the races.

Other indication examples include “health maintenance visit” and “routine visit dermatitis” among others.

Respiratory indication examples include “URI,” “strep pharyngitis,” and “acute bronchiolitis” among others.

d

e

7 (14.3%)

7 (10.5%)

Trauma/pain Indication examples include “fracture” and “accident” among others.

b

c

9 (18.4%)

13 (19.4%)

2 to <3

0 (0.0%)

0 (0.0%)

Trauma/Pain Indicationb, n (%)

Surgical Indication examples include “cleft lip,” “hypospadias,” and “hydrocephalus with VP shunt” among others.

a

3 (6.1%)

4 (6.0%)

Race/ethnicitye

0 (0.0%)

0 (0.0%)

1 to <2

Surgical Indicationa, n (%)

0 to <1

Age in months

Prescriptions, n (%)

8 (11.9%)

4 (50.0%)

4 (50.0%)

3 (37.5%)

1 (12.5%)

2 (25.0%)

2 (25.0%)

1 (12.5%)

3 (37.5%)

0 (0.0%)

3 (37.5%)

1 (12.5%)

—

“Other” Indicationd, n (%)

Indications for Use of Acetaminophen/Opioid Drugs by Infants 0 to < 6 Months Old, South Carolina Medicaid Data, 2011–2012.
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